SOX2 and neoplasm: Experiments have confirmed that knockdown of PHF20L1 or LSD1 in PA-1 cells and mouse ESCs leads to the loss of SOX2 protein stability and significantly impairs the self-renewal capacity of stem cells [44,45,46], which provides a new molecular basis for therapeutic strategies targeting SOX2-positive tumours (Figure 3B).